Elsevier

Clinical Therapeutics

Volume 23, Issue 8, August 2001, Pages 1296-1310
Clinical Therapeutics

A systematic review of the associations between dose regimens and medication compliance

https://doi.org/10.1016/S0149-2918(01)80109-0Get rights and content

Abstract

Background: Previous reviews of the literature on medication compliance have confirmed the inverse relationship between number of daily doses and rate of compliance. However, compliance in most of these studies was based on patient self-report, blood-level monitoring, prescription refills, or pill count data, none of which are as accurate as electronic monitoring (EM).

Objective: In this paper, we review studies in which compliance was measured with an EM device to determine the associations between dose frequency and medication compliance.

Methods: Articles included in this review were identified through literature searches of MEDLINE®, PsychInfo®, HealthStar, Health & Psychosocial Instruments, and the Cochrane Library using the search terms patient compliance, patient adherence, electronic monitoring, and MEMS (medication event monitoring systems). The review was limited to studies reporting compliance measured by EM devices, the most accurate compliance assessment method to date. Because EM was introduced only in 1986, the literature search was restricted to the years 1986 to 2000. In the identified studies, data were pooled to calculate mean compliance with once-daily, twice-daily, 3-times-daily, and 4-times-daily dosing regimens. Because of heterogeneity in definitions of compliance, 2 major categories of compliance rates were defined: dose-taking (taking the prescribed number of pills each day) and dose-timing (taking pills within the prescribed time frame).

Results: A total of 76 studies were identified. Mean dose-taking compliance was 71% ± 17% (range, 34%–97%) and declined as the number of daily doses increased: 1 dose = 79% ± 14%, 2 doses = 69% ± 15%, 3 doses = 65% ± 16%, 4 doses = 51% ± 20% (P < 0.001 among dose schedules). Compliance was significantly higher for once-daily versus 3-times-daily (P = 0.008), once-daily versus 4-times-daily (P < 0.001), and twice-daily versus 4-times-daily regimens (P = 0.001); however, there were no significant differences in compliance between once-daily and twice-daily regimens or between twice-daily and 3-times-daily regimens. In the subset of 14 studies that reported dose-timing results, mean dose-timing compliance was 59% ± 24%; more frequent dosing was associated with lower compliance rates.

Conclusions: A review of studies that measured compliance using EM confirmed that the prescribed number of doses per day is inversely related to compliance. Simpler, less frequent dosing regimens resulted in better compliance across a variety of therapeutic classes.

References (95)

  • ECM Ekstrom et al.

    Adherence to iron supplementation during pregnancy in Tanzania: Determinants and hematologic consequences

    Am J Clin Nutr

    (1996)
  • B Blackwell

    From compliance to alliance: A quarter century of research

    Neth J Med

    (1996)
  • K Demyttenaere

    Compliance during treatment with antidepressants

    J Affect Disord

    (1997)
  • JF Rosenbaum et al.

    Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial

    Biol Psychiatry

    (1998)
  • E Ridwan et al.

    Effects of weekly iron supplementation on pregnant Indonesian women are similar to those of daily supplementation

    Am J Clin Nutr

    (1996)
  • J Urquhart

    Ascertaining how much compliance is enough with outpatient antibiotic regimens

    Postgrad Med J

    (1992)
  • JA Cramer et al.

    How often is medication taken as prescribed?

    JAMA

    (1989)
  • P Rudd et al.

    The natural history of medication compliance in a drug trial: Limitations of pill counts

    Clin Pharmacol Ther

    (1989)
  • T Pullar et al.

    Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily

    Clin Pharmacol Ther

    (1988)
  • RN Greenberg

    Overview of patient compliance with medication dosing: A literature review

    Clin Ther

    (1984)
  • SA Eisen et al.

    The effect of prescribed daily dose frequency on patient medication compliance

    Arch Intern Med

    (1990)
  • SA Eisen et al.

    The effect of medication compliance on the control of hypertension

    J Gen Intern Med

    (1987)
  • R Cheung et al.

    The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community

    Br J Clin Pharmacol

    (1988)
  • KD Burney et al.

    Adherence to single daily dose of aspirin in a chemoprevention trial: An evaluation of self-report and microelectronic monitoring

    Arch Fam Med

    (1996)
  • R Day et al.

    Electronic monitoring of participant adherence in the NSABP breast cancer prevention trial

    Control Clin Trials

    (1998)
  • RCW Lau et al.

    Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia

    Med Pediatr Oncol

    (1998)
  • CR Lee et al.

    Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancer

    Eur J Gynaecol Oncol

    (1996)
  • DM Waterhouse et al.

    Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring

    J Clin Oncol

    (1993)
  • J Brun

    Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: A comparative study

    J Int Med Res

    (1994)
  • M Burnier et al.

    Objective monitoring of drug compliance: An important step in the management of hypertension resistant drug therapy

    Am J Hypertens

    (1999)
  • RM Carney et al.

    Major depression and medication adherence in elderly patients with coronary artery disease

    Health Psychol

    (1995)
  • JMR Detry et al.

    Patient compliance and therapeutic coverage: Comparison of amlodipine and slow release nifedipine in the treatment of hypertension

    Eur J Clin Pharmacol

    (1995)
  • D Guerrero et al.

    Antihypertensive medication-taking. Investigation of a simple regimen

    Am J Hypertens

    (1993)
  • W Kruse et al.

    Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring

    Eur J Clin Pharmacol

    (1993)
  • W Kruse et al.

    Measurement of drug compliance by continuous electronic monitoring: A pilot study in elderly patients discharged from hospital

    J Am Geriatr Soc

    (1992)
  • W Kruse et al.

    Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care

    Int J Clin Pharmacol Ther

    (1994)
  • FHH Leenen et al.

    Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring

    Can J Cardiol

    (1997)
  • MC Lueg et al.

    Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension

    Clin Ther

    (1991)
  • JM Mallion et al.

    Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment

    J Cardiovasc Pharmacol

    (1992)
  • JM Mallion et al.

    Behavior of patients with mild-to-moderate arterial hypertension in relation to their treatment. Contribution of an electronic pillbox [in French]

    Ann Cardiol Angeiol (Paris)

    (1995)
  • JM Mallion et al.

    Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension

    J Hypertens

    (1996)
  • JM Mallion et al.

    Compliance, electronic monitoring and antihypertensive drugs

    J Hypertens Suppl

    (1998)
  • T Mengden et al.

    The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening

    J Hypertens

    (1993)
  • P Rudd et al.

    Improved compliance measures: Applications in an ambulatory hypertensive drug trial

    Clin Pharmacol Ther

    (1990)
  • P Rudd et al.

    Antihypertensive drug trials, contributions from medication monitors

  • Cited by (0)

    This report was presented in part at the European Congress of Clinical Psychopharmacology, London, England, September 1999.

    View full text